NEI Research News

An experimental 'rescue' of retinas by treating eyes with certain stem cells has been shown to preserve visual function in mice that were genetically predisposed to degenerative diseases of the retina.

An important clinical trial, sponsored by the National Eye Institute(NEI), a part of the National Institutes of Health (NIH), has provided doctors with improved prognostic indicators and treatment options for retinopathy of prematurity.

Modest supplemental oxygen given to premature infants with moderate cases of retinopathy of prematurity (ROP), a potentially blinding eye disorder, may not significantly improve ROP, but definitely does not make it worse, according to researchers funded

A combination of anti-HIV drugs appears to help rejuvenate the immune systems of people with AIDS and prevent progression of cytomegalovirus (CMV) retinitis, a potentially blinding AIDS-related eye complication.

Researchers at the National Institutes of Health (NIH) have discovered a substance that allows people with uveitis, a potentially blinding eye disease, to stop or reduce the need for powerful drugs.

A combination of two antiviral drugs is more effective than either drug alone for controlling recurrences of a blinding eye infection common in people with AIDS, according to new clinical trial results from a federally-sponsored study.

Briefly freezing a portion of the eye’s surface can protect many premature infants against blindness from retinopathy of prematurity (ROP), a disease that causes visual loss in 2,600 infants in the United States annually.